Total Funding
89
76
Total FundingSeries B raised
Growth Score 89 in past quarter
-2 pts
Heat Score 76 in past quarter
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
59179
Nunaps is a digital therapeutics company developing AI and VR-based treatments for neurological and vision-related brain disorders.
- Cho Kyu Sok: Chief Financial Officer
- Lee Eun Jae: Chief Medical Officer
About the Company
Nunaps is a digital therapeutics company focused on developing AI and VR-based treatment solutions for neurological and vision-related brain disorders. It aims to improve recovery outcomes for patients with conditions such as brain injury–related vision impairment by using immersive and data-driven rehabilitation technologies designed to support
clinical treatment and patient recovery.